Endor at the ETP Nanomedicine General Assembly & Annual Forum 2010
An important initiative, led by industry, has been set up together with the European Commission. … Read more >
EMD is a medical solution that is designed and will be approved for the management and relief of pain associated with oral mucositis.
Oral mucositis is a common complication of cancer chemotherapy and radiotherapy, occurring in about 40% of patients.
EMD solution is the first product offering a triple action treatment:
- It provides an effective antimicrobial effect.
- It acts as a mucosa natural barrier.
- It promotes mucosa regeneration.
Clinical case studies will follow this study in order to register EDM as a medical device in Europe.